Ali Afrasiabi

176 Hawkesbury Rd
Westmead, NSW 2145, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Epstein-Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression.

Epstein-Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression.

Journal: Immunity, inflammation and disease

Published: July 31, 2025

TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells.

TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells.

Journal: Nature communications

Published: March 15, 2024

The interaction between Epstein-Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities.

The interaction between Epstein-Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities.

Journal: Clinical & translational immunology

Published: February 09, 2023

KARAJ: An Efficient Adaptive Multi-Processor Tool to Streamline Genomic and Transcriptomic Sequence Data Acquisition.

KARAJ: An Efficient Adaptive Multi-Processor Tool to Streamline Genomic and Transcriptomic Sequence Data Acquisition.

Journal: International journal of molecular sciences

Published: August 13, 2022

PeakCNV: A multi-feature ranking algorithm-based tool for genome-wide copy number variation-association study.

PeakCNV: A multi-feature ranking algorithm-based tool for genome-wide copy number variation-association study.

Journal: Computational and structural biotechnology journal

Published: June 15, 2022

Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.

Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.

Journal: Journal of autoimmunity

Published: October 05, 2021

The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionarily signature of ZAP.

The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionarily signature of ZAP.

Journal: Scientific reports

Published: September 17, 2021

Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells.

Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells.

Journal: Frontiers in immunology

Published: June 29, 2021

The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype.

The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype.

Journal: EBioMedicine

Published: May 22, 2021

Quantitative neurogenetics: applications in understanding disease.

Quantitative neurogenetics: applications in understanding disease.

Journal: Biochemical Society transactions

Published: April 20, 2021

The Interaction of Human and Epstein-Barr Virus miRNAs with Multiple Sclerosis Risk Loci.

The Interaction of Human and Epstein-Barr Virus miRNAs with Multiple Sclerosis Risk Loci.

Journal: International journal of molecular sciences

Published: January 29, 2021

Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol.

Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol.

Journal: BMJ open

Published: January 07, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026